Nicholas Schaub, MD
Surgical Oncology · Pikeville, KYNPI 1265693667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.
Across 202 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$558
- Merck$497
- Novartis$416
- Astellas Pharma US Inc$242
- E.r. Squibb & Sons, L.L.C.$207
- Regeneron Healthcare Solutions, Inc.$193
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,61693%
- Education$2687%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 39 | $558 |
| Merck | 27 | $497 |
| Novartis | 25 | $416 |
| Astellas Pharma US Inc | 6 | $242 |
| E.r. Squibb & Sons, L.L.C. | 13 | $207 |
| Regeneron Healthcare Solutions, Inc. | 10 | $193 |
| Davol Inc. | 2 | $186 |
| Johnson & Johnson(2 entities) | 8 | $178 |
| Genmab U.S., Inc. | 7 | $139 |
| AstraZeneca | 7 | $121 |
| Adaptive Biotechnologies Corporation | 3 | $114 |
| TELA Bio, Inc. | 1 | $76 |
| Amgen | 4 | $73 |
| Incyte Corporation | 4 | $66 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $62 |
| Genentech USA, Inc. | 2 | $61 |
| Bristol Myers Squibb | 3 | $61 |
| Stemline Therapeutics Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $52 |
| AbbVie | 3 | $50 |
| Eisai Inc. | 2 | $44 |
| Boehringer Ingelheim | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 2 | $37 |
| Coherus Oncology, Inc. | 2 | $34 |
| Pfizer | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 2 | $30 |
| Sanofi | 2 | $30 |
| Biom'up France SAS | 1 | $29 |
| AVEO Pharmaceuticals, Inc. | 2 | $27 |
| Tesaro, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Seagen Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| GSK | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Telix Pharmaceuticals | 1 | $14 |
| Exelixis Inc. | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PHASIX$137
How this compares
$3,884 in reported general payments places this provider in the 65th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 102 | $2,326 |
| Pantoprazole Sodium | 111 | $685 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $220 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Pikeville
- Robert MartinLouisville$483K
- Jennifer WhittingtonLexington$22K
- Charles ScogginsLouisville$15K
- Nicolas AjkayLouisville$11K
- Prejesh PhilipsLouisville$9K
- Prakash PandalaiLexington$8K
- Daniel KenadyHazard$6K
- Mary HughesAshland$5K
- Joseph GuentherEdgewood$5K
- Veronica JonesLexington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.